Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Tipus de document

Article

Versió

Versió publicada

Data de publicació

Llicència de publicació

cc-by (c) Pomares, Helena et al., 2016
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/132764

Targeting prohibitins induces apoptosis in acute myeloid leukemia cells

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

Fluorizoline is a new synthetic molecule that induces apoptosis by selectively targeting prohibitins (PHBs). In this study, the pro-apoptotic effect of fluorizoline was assessed in two cell lines and 21 primary samples from patients with debut of acute myeloid leukemia (AML). Fluorizoline induced apoptosis in AML cells at concentrations in the low micromolar range. All primary samples were sensitive to fluorizoline irrespectively of patients' clinical or genetic features. In addition, fluorizoline inhibited the clonogenic capacity and induced differentiation of AML cells. Fluorizoline increased the mRNA and protein levels of the pro-apoptotic BCL-2 family member NOXA both in cell lines and primary samples analyzed. These results suggest that targeting PHBs could be a new therapeutic strategy for AML

Matèries (anglès)

Citació

Citació

POMARES, Helena, et al. Targeting prohibitins induces apoptosis in acute myeloid leukemia cells. Oncotarget. 2016. Vol. 7, num. 40, pags. 64987-65000. ISSN 1949-2553. [consulted: 15 of August of 2026]. Available at: https://hdl.handle.net/2445/132764

Exportar metadades

JSON - METS

Compartir registre